BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) saw a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 57,100 shares, a drop of 20.5% from the June 30th total of 71,800 shares. Based on an average trading volume of 47,100 shares, the days-to-cover ratio is currently 1.2 days.
BetterLife Pharma Price Performance
OTCMKTS BETRF opened at $0.11 on Thursday. The company has a market cap of $5.52 million, a P/E ratio of -0.89 and a beta of 2.90. The stock has a 50-day moving average of $0.09 and a two-hundred day moving average of $0.11. BetterLife Pharma has a 1-year low of $0.05 and a 1-year high of $0.30.
Get BetterLife Pharma alerts:BetterLife Pharma (OTCMKTS:BETRF – Get Rating) last posted its quarterly earnings data on Tuesday, June 28th. The company reported ($0.03) EPS for the quarter.
About BetterLife Pharma
(Get Rating)BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.
Further Reading
- Get a free copy of the StockNews.com research report on BetterLife Pharma (BETRF)
- There Are Different Types of Stock To Invest In
- Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
- PayPal Continues To Struggle As Competition Increases
- Is Starbucks Shooting For The Moon?
- Two High-Yield Deep-Values You Shouldn't Ignore
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.